Detalles de la búsqueda
1.
The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia.
Blood
; 139(2): 177-187, 2022 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34758069
2.
Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia.
Ann Hematol
; 92(5): 653-60, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23340738
3.
Patient assessment and feasibility of treatment in older patients with cancer: results from the IN-GHO® Registry.
J Cancer Res Clin Oncol
; 147(11): 3183-3194, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34312732
4.
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.
Leukemia
; 34(4): 1038-1051, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32042081
5.
Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer.
Clin Colorectal Cancer
; 7(1): 60-4, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18279579
6.
Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort study.
Clin Epidemiol
; 7: 295-303, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25945067
7.
SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer.
Eur Urol
; 68(5): 837-47, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25952317
8.
Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group.
J Clin Oncol
; 25(27): 4217-23, 2007 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17548840
Resultados
1 -
8
de 8
1
Próxima >
>>